Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial
Primary Purpose
Fibromyalgia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TrainPain
Sponsored by
About this trial
This is an interventional device feasibility trial for Fibromyalgia focused on measuring Gamified, Somatosensory, Temporal discrimination, Cognitive training, Chronic Pain
Eligibility Criteria
Inclusion Criteria:
- Ages between 18 and 65 at consent
- Chronic pain ( at least 3 months)
- Minimum average pain of 4 in the NRS
Exclusion Criteria:
- Not able to comprehend English written language
- Chronic skin disease or topical allergies that would be worsened by the use of sensor tape
- Severe psychiatric disorder (Patient Health Questionnaire)
Sites / Locations
- Icahn School of Medicine at Mount Sinai
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
TrainPain Intervention
Arm Description
Daily TrainPain protocol - gamified sensory perceptual training
Outcomes
Primary Outcome Measures
Retention rates
Retention rates to assess the feasibility of at-home somatosensorial training technology for people with fibromyalgia
Adherence rates
Adherence rates to the assess feasibility of at-home somatosensorial training technology for people with fibromyalgia
The System Usability Score
Though the scores are 0-100, these are not percentages and should be considered only in terms of their percentile ranking.
The Net Promoter Score
The Net Promoter Score is an index ranging from 0-10 that measures the willingness of customers to recommend a company's products or services to others as a measure of opinion on the feasibility on using the device. Higher score indicates higher recommendation.
The Subjective Feedback Questionnaire
The Subjective Feedback Questionnaire asks participants to rate the acceptability, enjoyment, and perceived usefulness (0-10) of the program as a measure of opinion on the feasibility on using the device. Higher score indicates higher enjoyment. There are also 12 subjective yes/no questions asking participants to report their opinions of the program and its affect on their pain and quality of life. Finally, there are two open-ended questions that give participants the opportunity to provide feedback on the program.
Secondary Outcome Measures
Change The Pain, Enjoyment of Life and General Activity (PEG) Scale
The Pain, Enjoyment of Life and General Activity (PEG) Scale consists of 3 separate numerical scales. Each scale has ratings ranging from 0-10. The PEG scale is scored by averaging the three numbers. Full scale from 0-10, higher score indicates worse pain, and pain interference. Change in score at 5 weeks compared to baseline.
Change Patient Global Impression of Change (PGIC)
The Patient's Global Impression of Change (PGIC) Full score from -3 to 3, with higher score indicating more improvement. Change in score at 5 weeks compared to baseline.
Pain Catastrophizing Scale (PCS)
The PCS contains 13 questions. The full score ranges from 0 to 39 where a higher score correlates with more extreme pain catastrophization.
Change in Fibromyalgia Assessment Scale (FAS)
Fibromyalgia Assessment Scale (FAS) is a short and easy to complete self-administered index combining a set of questions relating to non-articular pain (SAPS range 0 to 10), fatigue (range 0 to 10), and the quality of sleep (range 0 to 10) that provides a single composite measure of disease activity ranging from 0 to 10. higher score indicates poorer health outcomes. Change in score at 5 weeks compared to baseline.
Full Information
NCT ID
NCT04919525
First Posted
May 5, 2021
Last Updated
June 14, 2022
Sponsor
Icahn School of Medicine at Mount Sinai
1. Study Identification
Unique Protocol Identification Number
NCT04919525
Brief Title
Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial
Official Title
Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
March 18, 2021 (Actual)
Primary Completion Date
June 3, 2022 (Actual)
Study Completion Date
June 3, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Icahn School of Medicine at Mount Sinai
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine the feasibility of gamified sensory perceptual training in people with fibromyalgia. The primary aim is to determine the feasibility of at-home somatosensorial training for people with fibromyalgia. The researchers are determining the feasibility of using this device to decrease chronic neuropathic pain in people with fibromyalgia. The secondary aim is to survey participants' subjective report of clinical change after this program.
Detailed Description
Fibromyalgia is a pain syndrome characterized by central sensitization, and hypersensitivity to nociceptive stimuli. In people with fibromyalgia, objective measures of sensory perception are often impaired. For example, somatosensory temporal discrimination thresholds are elevated, and this correlates with increased widespread pain and severity of other symptoms including fatigue, sleep quality, cognitive symptoms, somatic symptoms and decreased functional status. Sensory-Cognitive training may reduce symptoms by improving attentional modulation of somatosensory signals, improving precision of sensory discrimination, and altering affective processing of somatosensation. The objective of this study is to evaluate the feasibility of the TrainPain program as a somatosensory therapy for people with fibromyalgia.. This study plans to enroll 30 participants between the ages of 18 and 65 who are diagnosed with fibromyalgia and have been experiencing chronic pain with an NRS rating of 4/10 for at least 3 months. All participants who agree to participate in this study will answer a set of baseline questionnaires (PEG, FAS) about their symptoms at the time of inclusion. Participants will also receive the device, and view a demonstration of how to use the technology. The technology consists of two components; (1) an application downloaded to the participants' smartphone and (2) two vibrational devices to be placed on the body of the participant, connected to the application via bluetooth. Participants will use this technology once daily for 28 days. Participants will complete a 15 minute sensory training session using the provided technology; additionally, participants will receive daily text messages to promote pain self-management, and program adherence. Participants will also complete the PEG questionnaire once weekly. After 28 days study team members will conduct a virtual follow-up visit. In that visit, participants will complete the same questionnaires as at baseline (PEG, FAS), as well as a question on their perception of clinical change (PGIC). Participants will also be asked to complete the system usability scale and provide a net promoter score. Finally, participants will complete a subjective feedback questionnaire where they will rate whether participating in this program was time well spent and enjoyable. The primary aim is to determine the feasibility of at-home somatosensorial training for people with fibromyalgia. The secondary aim is to survey participants' subjective report of clinical change after this.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia
Keywords
Gamified, Somatosensory, Temporal discrimination, Cognitive training, Chronic Pain
7. Study Design
Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
11 (Actual)
8. Arms, Groups, and Interventions
Arm Title
TrainPain Intervention
Arm Type
Experimental
Arm Description
Daily TrainPain protocol - gamified sensory perceptual training
Intervention Type
Device
Intervention Name(s)
TrainPain
Intervention Description
Participants will use gamified sensory perceptual training technology once daily for 28 days. This will involve participants completing a 15 minute sensory training session using the provided technology and viewing a 5 minute web based pain management lesson; additionally, participants will receive daily text messages. The device used in this study has two components. The first is a video game that can be downloaded onto any smartphone device. The second component is two vibrational devices that can be attached to the arms, legs, upper back, and lower back.
Primary Outcome Measure Information:
Title
Retention rates
Description
Retention rates to assess the feasibility of at-home somatosensorial training technology for people with fibromyalgia
Time Frame
5 weeks
Title
Adherence rates
Description
Adherence rates to the assess feasibility of at-home somatosensorial training technology for people with fibromyalgia
Time Frame
5 weeks
Title
The System Usability Score
Description
Though the scores are 0-100, these are not percentages and should be considered only in terms of their percentile ranking.
Time Frame
5 weeks
Title
The Net Promoter Score
Description
The Net Promoter Score is an index ranging from 0-10 that measures the willingness of customers to recommend a company's products or services to others as a measure of opinion on the feasibility on using the device. Higher score indicates higher recommendation.
Time Frame
5 weeks
Title
The Subjective Feedback Questionnaire
Description
The Subjective Feedback Questionnaire asks participants to rate the acceptability, enjoyment, and perceived usefulness (0-10) of the program as a measure of opinion on the feasibility on using the device. Higher score indicates higher enjoyment. There are also 12 subjective yes/no questions asking participants to report their opinions of the program and its affect on their pain and quality of life. Finally, there are two open-ended questions that give participants the opportunity to provide feedback on the program.
Time Frame
5 weeks
Secondary Outcome Measure Information:
Title
Change The Pain, Enjoyment of Life and General Activity (PEG) Scale
Description
The Pain, Enjoyment of Life and General Activity (PEG) Scale consists of 3 separate numerical scales. Each scale has ratings ranging from 0-10. The PEG scale is scored by averaging the three numbers. Full scale from 0-10, higher score indicates worse pain, and pain interference. Change in score at 5 weeks compared to baseline.
Time Frame
Baseline and 5 weeks
Title
Change Patient Global Impression of Change (PGIC)
Description
The Patient's Global Impression of Change (PGIC) Full score from -3 to 3, with higher score indicating more improvement. Change in score at 5 weeks compared to baseline.
Time Frame
Baseline and 5 weeks
Title
Pain Catastrophizing Scale (PCS)
Description
The PCS contains 13 questions. The full score ranges from 0 to 39 where a higher score correlates with more extreme pain catastrophization.
Time Frame
Baseline and 5 weeks
Title
Change in Fibromyalgia Assessment Scale (FAS)
Description
Fibromyalgia Assessment Scale (FAS) is a short and easy to complete self-administered index combining a set of questions relating to non-articular pain (SAPS range 0 to 10), fatigue (range 0 to 10), and the quality of sleep (range 0 to 10) that provides a single composite measure of disease activity ranging from 0 to 10. higher score indicates poorer health outcomes. Change in score at 5 weeks compared to baseline.
Time Frame
Baseline and 5 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Ages between 18 and 65 at consent
Chronic pain ( at least 3 months)
Minimum average pain of 4 in the NRS
Exclusion Criteria:
Not able to comprehend English written language
Chronic skin disease or topical allergies that would be worsened by the use of sensor tape
Severe psychiatric disorder (Patient Health Questionnaire)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laura Tabacof, MD
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Principal Investigator
Facility Information:
Facility Name
Icahn School of Medicine at Mount Sinai
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial
We'll reach out to this number within 24 hrs